CN115246938A - Silk fibroin hydrogel with traditional Chinese medicine polysaccharide activity, and preparation method and application thereof - Google Patents
Silk fibroin hydrogel with traditional Chinese medicine polysaccharide activity, and preparation method and application thereof Download PDFInfo
- Publication number
- CN115246938A CN115246938A CN202011510562.2A CN202011510562A CN115246938A CN 115246938 A CN115246938 A CN 115246938A CN 202011510562 A CN202011510562 A CN 202011510562A CN 115246938 A CN115246938 A CN 115246938A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- silk fibroin
- preparation
- solution
- polysaccharide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229920001282 polysaccharide Polymers 0.000 title claims abstract description 84
- 239000005017 polysaccharide Substances 0.000 title claims abstract description 84
- 150000004676 glycans Chemical class 0.000 title claims abstract description 78
- 108010022355 Fibroins Proteins 0.000 title claims abstract description 71
- 239000003814 drug Substances 0.000 title claims abstract description 58
- 239000000017 hydrogel Substances 0.000 title claims abstract description 45
- 238000002360 preparation method Methods 0.000 title claims abstract description 31
- 230000000694 effects Effects 0.000 title claims abstract description 25
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 49
- 238000000034 method Methods 0.000 claims abstract description 15
- 239000000243 solution Substances 0.000 claims description 59
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 28
- 238000000502 dialysis Methods 0.000 claims description 19
- AMXOYNBUYSYVKV-UHFFFAOYSA-M lithium bromide Chemical compound [Li+].[Br-] AMXOYNBUYSYVKV-UHFFFAOYSA-M 0.000 claims description 16
- 102000004169 proteins and genes Human genes 0.000 claims description 14
- 108090000623 proteins and genes Proteins 0.000 claims description 14
- 239000000499 gel Substances 0.000 claims description 13
- 239000000463 material Substances 0.000 claims description 12
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 10
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 10
- 238000005119 centrifugation Methods 0.000 claims description 8
- 239000011259 mixed solution Substances 0.000 claims description 7
- 238000001556 precipitation Methods 0.000 claims description 6
- 230000002378 acidificating effect Effects 0.000 claims description 5
- 239000008367 deionised water Substances 0.000 claims description 5
- 229910021641 deionized water Inorganic materials 0.000 claims description 5
- 239000000706 filtrate Substances 0.000 claims description 5
- 239000012535 impurity Substances 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 5
- 239000012567 medical material Substances 0.000 claims description 5
- 238000003809 water extraction Methods 0.000 claims description 5
- 230000015572 biosynthetic process Effects 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- 239000012141 concentrate Substances 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 2
- 238000000967 suction filtration Methods 0.000 claims description 2
- 238000012869 ethanol precipitation Methods 0.000 claims 1
- 238000001879 gelation Methods 0.000 description 11
- 235000006533 astragalus Nutrition 0.000 description 9
- 241001061264 Astragalus Species 0.000 description 5
- 238000010382 chemical cross-linking Methods 0.000 description 5
- 239000003431 cross linking reagent Substances 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 210000004233 talus Anatomy 0.000 description 5
- -1 0.2 to 1 mL Chemical compound 0.000 description 4
- 241000045403 Astragalus propinquus Species 0.000 description 4
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 229940098773 bovine serum albumin Drugs 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 238000004108 freeze drying Methods 0.000 description 3
- 241000756042 Polygonatum Species 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000004663 cell proliferation Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 238000001000 micrograph Methods 0.000 description 2
- 238000013508 migration Methods 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 1
- 241000893536 Epimedium Species 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 240000002045 Guettarda speciosa Species 0.000 description 1
- 235000001287 Guettarda speciosa Nutrition 0.000 description 1
- 235000009411 Rheum rhabarbarum Nutrition 0.000 description 1
- 241000219063 Rheum rhabarbarum [NCBITaxon:3621] Species 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 230000021164 cell adhesion Effects 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000012292 cell migration Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 235000018905 epimedium Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000012460 protein solution Substances 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/02—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques
- C08J3/03—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in aqueous media
- C08J3/075—Macromolecular gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0003—General processes for their isolation or fractionation, e.g. purification or extraction from biomass
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2305/00—Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2301/00 or C08J2303/00
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2389/00—Characterised by the use of proteins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2405/00—Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2401/00 or C08J2403/00
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2489/00—Characterised by the use of proteins; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Dispersion Chemistry (AREA)
- Molecular Biology (AREA)
- Polymers & Plastics (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Sustainable Development (AREA)
- Biochemistry (AREA)
- Materials Engineering (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
技术领域technical field
本发明涉及水凝胶制备技术领域,特别是涉及一种具有中药多糖活性的丝素蛋白水凝胶、及其制备方法和应用。The invention relates to the technical field of hydrogel preparation, in particular to a silk fibroin hydrogel with traditional Chinese medicine polysaccharide activity, a preparation method and application thereof.
背景技术Background technique
丝素蛋白由蚕丝经过脱胶制得,是一种无生理活性的天然高分子纤维蛋白,占蚕丝的70%~80%,是含有人体必需氨基酸的天然蛋白质,且具有良好的生物相容性。丝素蛋白存在SilkI和SilkII两种不同的构象,SilkI构象包括无规则线团和a-螺旋,SilkII构象则为反平行β-折叠。其中,SilkI结构不够稳定,经极性溶剂、热处理等可转变成稳定的SilkII结构。丝素蛋白可通过相对简单的处理获得多种不同的形态有利于组织细胞长入。Silk fibroin is obtained by degumming silk. It is a natural macromolecular fibrin with no physiological activity, accounting for 70% to 80% of silk. It is a natural protein containing essential amino acids for human body and has good biocompatibility. Silk fibroin exists in two different conformations, Silk I and Silk II. The conformation of Silk I includes random coil and a-helix, while the conformation of Silk II is anti-parallel β-sheet. Among them, the SilkI structure is not stable enough, and can be converted into a stable SilkII structure by polar solvents, heat treatment, etc. Silk fibroin can be obtained in a variety of different forms through relatively simple processing, which is conducive to the ingrowth of tissue cells.
多糖是植物的主要成分,许多多糖具有重要的药理活性,中药多糖水凝胶无毒且具有良好的保水性能、生物相容性和生物降解性,其在药物释放系统有良好的应用前景。Polysaccharides are the main components of plants. Many polysaccharides have important pharmacological activities. Traditional Chinese medicine polysaccharide hydrogels are non-toxic and have good water retention properties, biocompatibility and biodegradability. They have good application prospects in drug delivery systems.
丝素蛋白溶液在静置下会逐渐向凝胶化转变,但是,转化时间较长,而且丝素蛋白的质量浓度对于凝胶时间也有影响,例如,丝素蛋白溶液在质量浓度大于10%时比较容易形成凝胶,但是在质量浓度小于10%时需要很长的时间才能形成凝胶。而且质量浓度高于10%的丝素蛋白溶液形成的凝胶含水量较低、孔隙率也较低,在应用时也会受到一定的限制。质量浓度低于5%的丝素溶液凝胶化时间太长也制约了丝素蛋白水凝胶的使用。The silk fibroin solution will gradually change to gelation under standing, however, the transformation time is long, and the mass concentration of silk fibroin also affects the gelation time. For example, when the mass concentration of silk fibroin solution is greater than 10% It is easier to form a gel, but it takes a long time to form a gel when the mass concentration is less than 10%. Moreover, the gel formed by the silk fibroin solution with a mass concentration higher than 10% has a lower water content and a lower porosity, and is also limited in application. The long gelation time of silk fibroin solution with a mass concentration of less than 5% also restricts the use of silk fibroin hydrogels.
目前,缩短丝素蛋白水凝胶时间的主要方法是:向丝素蛋白水溶液中加入化学交联剂,此方法虽然能够大大的缩短丝素蛋白水溶液凝胶化的时间,但是,所制得的凝胶中会残留一定量的化学交联剂,带来一定的毒性,而且该方法还降低了丝素蛋白水凝胶的生物相容性。At present, the main method for shortening the hydrogelation time of silk fibroin is: adding a chemical cross-linking agent to the silk fibroin aqueous solution. Although this method can greatly shorten the gelation time of the silk fibroin aqueous solution, the obtained A certain amount of chemical cross-linking agent will remain in the gel, which brings certain toxicity, and this method also reduces the biocompatibility of silk fibroin hydrogels.
因此,如何将低浓度的丝素蛋白溶液在短时间内成胶成为目前研究的重点。Therefore, how to gel the low-concentration silk fibroin solution in a short time has become the focus of current research.
发明内容SUMMARY OF THE INVENTION
基于此,本发明的目的在于提供一种具有中药多糖活性的丝素蛋白水凝胶、及其制备方法和应用。本发明通过加入一定体积的中药多糖和乙醇调pH值至酸性,从而将丝素蛋白溶液的成胶时间缩短至5min以内,提高了工作效率;而且制备得到的水凝胶的生物相容性良好,不含有化学交联剂,绿色安全;本发明具有制备工艺简单、成本较低、快速、高效等优点,可广泛应用关于医药材料行业。Based on this, the purpose of the present invention is to provide a silk fibroin hydrogel with Chinese medicine polysaccharide activity, and a preparation method and application thereof. In the present invention, by adding a certain volume of traditional Chinese medicine polysaccharide and ethanol to adjust the pH value to be acidic, the gelation time of the silk fibroin solution is shortened to less than 5 minutes, and the work efficiency is improved; and the prepared hydrogel has good biocompatibility , does not contain chemical cross-linking agent, green and safe; the invention has the advantages of simple preparation process, low cost, rapidity, high efficiency, etc., and can be widely used in the medical material industry.
本发明的上述目的是通过以下技术方案实现的:Above-mentioned purpose of the present invention is achieved through the following technical solutions:
根据本发明的一个方面,本发明提供的一种具有中药多糖活性的丝素蛋白水凝胶的制备方法,包括:According to one aspect of the present invention, a preparation method of silk fibroin hydrogel with Chinese medicine polysaccharide activity provided by the present invention comprises:
将浓度为1%~6%的丝素蛋白溶液,与浓度为0.2~4%中药多糖混合,得到混合溶液;Mixing the silk fibroin solution with a concentration of 1% to 6% and the traditional Chinese medicine polysaccharide with a concentration of 0.2% to 4% to obtain a mixed solution;
加入乙醇调节所述混合溶液pH值至酸性,成胶,得到具有中药多糖活性的丝素蛋白水凝胶。Ethanol is added to adjust the pH value of the mixed solution to be acidic to form a gel to obtain a silk fibroin hydrogel with Chinese medicine polysaccharide activity.
优选地,所述丝素蛋白溶液浓度为1%~4%。Preferably, the concentration of the silk fibroin solution is 1% to 4%.
优选地,所述中药多糖的浓度为0.2~2%。Preferably, the concentration of the traditional Chinese medicine polysaccharide is 0.2-2%.
优选地,所述丝素蛋白溶液与中药多糖的体积比为1:(0.25~4)。更优选地,所述丝素蛋白溶液与中药多糖的体积比可以为1:(0.25~3)。Preferably, the volume ratio of the silk fibroin solution to the traditional Chinese medicine polysaccharide is 1:(0.25-4). More preferably, the volume ratio of the silk fibroin solution to the traditional Chinese medicine polysaccharide may be 1:(0.25-3).
优选地,所加入的乙醇浓度为70%~100%。Preferably, the added ethanol concentration is 70% to 100%.
优选地,调节所述混合溶液pH值为4~6。Preferably, the pH value of the mixed solution is adjusted to 4-6.
优选地,成胶的温度为25℃~50℃。Preferably, the temperature for gel formation is 25°C to 50°C.
优选地,所述丝素蛋白溶液的制备方法,包括:将脱胶蚕丝置于9.3M溴化锂溶液中,水浴加热溶解;将溶液冷却至室温,透析;然后离心处理,除去杂质,得到丝素蛋白溶液。Preferably, the preparation method of the silk fibroin solution includes: placing the degummed silk in a 9.3M lithium bromide solution, heating and dissolving in a water bath; cooling the solution to room temperature, and dialysis; then centrifuging to remove impurities to obtain a silk fibroin solution .
进一步地,水浴加热溶解时,脱胶蚕丝与溴化锂溶液的水浴比为1:(5~10),水浴温度为65℃。透析时,采用截留分子量为14000的透析袋于4℃透析3d。离心条件为:温度4℃,转速9000r/min,离心时间20min。Further, when the water bath is heated and dissolved, the water bath ratio of the degummed silk and the lithium bromide solution is 1:(5-10), and the water bath temperature is 65°C. During dialysis, a dialysis bag with a molecular weight cut-off of 14,000 was used for dialysis at 4°C for 3 d. The centrifugation conditions were: temperature 4°C, rotation speed 9000r/min, and centrifugation time 20min.
优选地,所述中药多糖采用水提醇沉法提取中药多糖,采用Sevag法除蛋白得到,其中,提取液:氯仿:正丁醇=25:5:1。Preferably, the traditional Chinese medicine polysaccharide is obtained by extracting the traditional Chinese medicine polysaccharide by water extraction and alcohol precipitation, and using the Sevag method to remove protein, wherein the extract: chloroform: n-butanol=25:5:1.
进一步地,所述中药多糖的制备方法,包括:取机械粉碎后的中药材,按料液比置于水浴锅提取多次,合并滤液后浓缩,采用Sevag法除蛋白;将除蛋白后的多糖溶液用乙醇醇沉、抽滤、干燥、得到中药粗多糖;将所述中药粗多糖在去离子水中透析,冷冻干燥得到中药多糖。其中,醇沉时乙醇的体积用量约为除蛋白后多糖溶液的4倍。其中,所述中药材可以为黄芪药材、黄精药材、当归药材、大黄药材、淫羊藿药材等。Further, the preparation method of the traditional Chinese medicine polysaccharide includes: taking the mechanically pulverized Chinese medicinal material, placing it in a water bath to extract multiple times according to the material-to-liquid ratio, combining the filtrates and concentrating, and using the Sevag method to remove protein; The solution is alcohol-precipitated with ethanol, suction filtered, and dried to obtain the traditional Chinese medicine crude polysaccharide; the traditional Chinese medicine crude polysaccharide is dialyzed in deionized water, and freeze-dried to obtain the traditional Chinese medicine polysaccharide. Among them, the volume dosage of ethanol during alcohol precipitation is about 4 times that of the polysaccharide solution after protein removal. Wherein, the Chinese medicinal materials can be astragalus medicinal materials, Huang Jing medicinal materials, Angelica medicinal materials, Rhubarb medicinal materials, Epimedium medicinal materials and the like.
根据本发明的另一个方面,本发明提供的一种具有中药多糖活性的丝素蛋白水凝胶,所述水凝胶采用上述的制备方法制备得到。According to another aspect of the present invention, the present invention provides a silk fibroin hydrogel with traditional Chinese medicine polysaccharide activity, which is prepared by the above-mentioned preparation method.
根据本发明的还一个方面,本发明提供的一种具有中药多糖活性的丝素蛋白水凝胶在医药材料中的应用,所述水凝胶采用上述的制备方法制备得到。具体地,所述医药材料例如可以为肠溶性材料、药物释放及细胞培养材料、可注射水凝胶等。According to yet another aspect of the present invention, the present invention provides the application of a silk fibroin hydrogel with traditional Chinese medicine polysaccharide activity in medical materials, wherein the hydrogel is prepared by the above-mentioned preparation method. Specifically, the medical material can be, for example, an enteric material, a drug release and cell culture material, an injectable hydrogel, and the like.
与现有技术相比,本发明通过在浓度为1%~6%的丝素蛋白溶液中加入中药多糖和乙醇调pH值至酸性的方式得到丝素蛋白水凝胶,缩短了低浓度丝素蛋白溶液的成胶时间,且可缩短至5min以内,提高了工作效率,解决了现有技术中因丝素溶液凝胶化时间太长而制约丝素蛋白水凝胶使用的问题,同时也避免了向丝素蛋白水溶液中加入化学交联剂而带来毒性,降低水凝胶生物相容性的问题。而且,本发明通过加入中药多糖,可使水凝胶具有多糖活性,使水凝胶具有促细胞增殖作用。本发明所制备的水凝胶具有明显的三维网状结构,多孔的内部结构、孔隙间的相互连接,可应用于药物释放,有利于细胞的粘附和迁移。Compared with the prior art, the present invention obtains the silk fibroin hydrogel by adding traditional Chinese medicine polysaccharide and ethanol to the silk fibroin solution with a concentration of 1% to 6% to adjust the pH value to be acidic, and shortens the time of low-concentration silk fibroin. The gelation time of the protein solution can be shortened to less than 5min, which improves the work efficiency, solves the problem of restricting the use of silk fibroin hydrogel in the prior art because the gelation time of the silk fibroin solution is too long, and also avoids the In order to bring toxicity to the silk fibroin aqueous solution, the chemical cross-linking agent will reduce the biocompatibility of the hydrogel. Moreover, the present invention can make the hydrogel have polysaccharide activity by adding traditional Chinese medicine polysaccharide, so that the hydrogel has the effect of promoting cell proliferation. The hydrogel prepared by the invention has an obvious three-dimensional network structure, a porous internal structure and interconnected pores, which can be used for drug release and is beneficial to the adhesion and migration of cells.
本发明具有制备工艺简单、成本较低、快速、高效等优点;还具有对温度敏感、酸性敏感、且可注射等优点。而且本发明制备得到的水凝胶的生物相容性良好,且不含有化学交联剂等,绿色安全,可广泛应用于医药材料行业中。The present invention has the advantages of simple preparation process, low cost, rapidity, high efficiency, etc., and also has the advantages of being sensitive to temperature, sensitive to acidity, and injectable. Moreover, the hydrogel prepared by the invention has good biocompatibility, does not contain chemical cross-linking agents, etc., is green and safe, and can be widely used in the medical material industry.
另外,本发明通过对各比例、浓度等参数范围进行不断的研究,最终得到了本发明所述的可选和优选范围,且低浓度的多糖、低浓度的丝素蛋白以及无水乙醇成胶更快。本发明通过加入所述体积的中药多糖和所述浓度范围内的乙醇调pH值至酸性,从而将丝素蛋白溶液的成胶时间缩短至5min以内,甚至可以缩短至1min左右,大大地提高了工作效率;且本发明通过加入中药多糖,可使水凝胶具有多糖活性,使水凝胶具有促细胞增殖作用。In addition, the present invention finally obtains the optional and preferred ranges described in the present invention through continuous research on the ranges of parameters such as ratios and concentrations, and the low-concentration polysaccharide, low-concentration silk fibroin and absolute ethanol form a gel faster. In the present invention, by adding the volume of traditional Chinese medicine polysaccharide and ethanol within the concentration range to adjust the pH value to be acidic, the gelation time of the silk fibroin solution can be shortened to less than 5 minutes, and even can be shortened to about 1 minute, which greatly improves the Work efficiency; and the present invention can make the hydrogel have polysaccharide activity by adding traditional Chinese medicine polysaccharide, so that the hydrogel has the effect of promoting cell proliferation.
附图说明Description of drawings
图1是本发明制得的具有中药多糖活性的丝素蛋白水凝胶;Fig. 1 is the silk fibroin hydrogel with Chinese medicine polysaccharide activity that the present invention makes;
图2是本发明实施例1制备的具有中药多糖活性的丝素蛋白水凝胶包被牛血清白蛋白的释放曲线图;Fig. 2 is the release curve diagram of bovine serum albumin coated with silk fibroin hydrogel with Chinese medicine polysaccharide activity prepared in Example 1 of the present invention;
图3是本发明实施例2制备的具有中药多糖活性的丝素蛋白水凝胶的扫描电镜图。FIG. 3 is a scanning electron microscope image of the silk fibroin hydrogel with Chinese medicine polysaccharide activity prepared in Example 2 of the present invention.
具体实施方式Detailed ways
下面结合实施例对本发明的技术方案进行清楚、完整地描述,显然,所描述的实施例仅仅是本发明一部分实施例,而不是全部的实施例。以下对至少一个示例性实施例的描述实际上仅仅是说明性的,决不作为对本发明及其应用或使用的任何限制。基于发明中的实施例,本领域普通技术人员在没有作出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。The technical solutions of the present invention will be clearly and completely described below with reference to the embodiments. Obviously, the described embodiments are only a part of the embodiments of the present invention, rather than all the embodiments. The following description of at least one exemplary embodiment is merely illustrative in nature and is in no way intended to limit the invention, its application, or uses. Based on the embodiments in the invention, all other embodiments obtained by persons of ordinary skill in the art without creative efforts shall fall within the protection scope of the present invention.
本发明提供的一种具有中药多糖活性的丝素蛋白水凝胶的制备方法,可以包括以下步骤:A preparation method of a silk fibroin hydrogel with Chinese medicine polysaccharide activity provided by the present invention may include the following steps:
一、利用水提醇沉法提取中药粗多糖:1. Use water extraction and alcohol precipitation to extract crude polysaccharides from traditional Chinese medicine:
1)取一定质量的机械粉碎后的中药材,按料液比1:10置于80℃水浴锅提取3次,合并滤液后浓缩至一定体积,用Sevag法除蛋白。其中,提取液:氯仿:正丁醇=25:5:1。1) Take a certain quality of mechanically pulverized Chinese herbal medicine, place it in a water bath at 80°C for 3 times extraction at a material-to-liquid ratio of 1:10, combine the filtrates and concentrate to a certain volume, and use the Sevag method to remove protein. Wherein, extract: chloroform: n-butanol=25:5:1.
2)将除蛋白后的多糖溶液用一定体积95%乙醇醇沉、抽滤、干燥得到中药粗多糖。其中,所述乙醇的体积用量可以为除蛋白后多糖溶液的4倍。2) Precipitating the polysaccharide solution after protein removal with a certain volume of 95% ethanol, suction filtration, and drying to obtain crude polysaccharide of traditional Chinese medicine. Wherein, the volume dosage of the ethanol can be 4 times that of the polysaccharide solution after protein removal.
二、制备中药多糖:2. Preparation of traditional Chinese medicine polysaccharides:
3)将上述干燥的中药粗多糖在去离子水中透析3d,冷冻干燥得到中药多糖,备用;透析时,透析袋的截留分子量为3500,透析时间3d。3) Dialyzing the above-mentioned dried Chinese medicine crude polysaccharide in deionized water for 3 d, freeze-drying to obtain the traditional Chinese medicine polysaccharide, for use; during dialysis, the molecular weight cut-off of the dialysis bag is 3500, and the dialysis time is 3 d.
三、制备丝素蛋白溶液:3. Preparation of silk fibroin solution:
4)将一定质量脱胶蚕丝置于9.3M溴化锂溶液中,在65℃水浴锅中加热充分溶解后,将溶液冷却至室温转移至透析袋中,低温下置于蒸馏水中透析3d。透析结束后,将溶液置于离心机中离心,除去不溶杂质,获得澄清的丝素蛋白溶液。其中,脱胶蚕丝与溴化锂溶液的水浴比为1:(5~10)。透析时,采用截留分子量为14000的透析袋于4℃透析3d。离心条件为:温度4℃、转速9000r/min,离心时间20min。4) A certain quality of degummed silk was placed in a 9.3M lithium bromide solution, heated in a 65°C water bath to fully dissolve, cooled to room temperature, transferred to a dialysis bag, and dialyzed in distilled water at low temperature for 3 days. After the dialysis, the solution was centrifuged in a centrifuge to remove insoluble impurities to obtain a clear silk fibroin solution. Wherein, the water bath ratio of degummed silk and lithium bromide solution is 1:(5~10). During dialysis, a dialysis bag with a molecular weight cut-off of 14,000 was used for dialysis at 4°C for 3 d. The centrifugation conditions were: temperature 4°C, rotation speed 9000r/min, and centrifugation time 20min.
四、制备具有中药多糖活性的丝素蛋白水凝胶:4. Preparation of silk fibroin hydrogel with traditional Chinese medicine polysaccharide activity:
5)将浓度为1%~6%的丝素蛋白溶液与浓度为0.2~4%的中药多糖按不同体积比混合,加入一定体积乙醇,例如0.2~1mL,将混合液pH值调至酸性,例如调至pH为4~6,置于不同温度中,例如室温、37℃、50℃中,观察成胶时间。其中,所述丝素蛋白溶液与中药多糖的体积比可以为1:(0.25~4),优选1:(0.25~3),例如可以按照1:4、2:3、1:1、3:2、4:1混合。所述乙醇浓度为70%~100%。进一步地,所述丝素蛋白溶液浓度优选1%~4%。所述中药多糖的浓度优选0.2~2%。乙醇优选无水乙醇。低浓度的多糖、低浓度的丝素蛋白和无水乙醇会成胶更快。5) Mix the silk fibroin solution with a concentration of 1% to 6% and the traditional Chinese medicine polysaccharide with a concentration of 0.2 to 4% in different volume ratios, add a certain volume of ethanol, such as 0.2 to 1 mL, and adjust the pH of the mixture to acidity, For example, adjust the pH to 4-6, place it at different temperatures, such as room temperature, 37°C, and 50°C, and observe the gel formation time. Wherein, the volume ratio of the silk fibroin solution to the traditional Chinese medicine polysaccharide can be 1:(0.25-4), preferably 1:(0.25-3), for example, it can be 1:4, 2:3, 1:1, 3: 2. 4:1 mix. The ethanol concentration is 70% to 100%. Further, the concentration of the silk fibroin solution is preferably 1% to 4%. The concentration of the traditional Chinese medicine polysaccharide is preferably 0.2-2%. Ethanol is preferably absolute ethanol. Low concentrations of polysaccharides, low concentrations of silk fibroin and absolute ethanol will gel faster.
6)成胶时间确定:将离心管倒置,溶液不流动,即得到具有中药多糖活性的丝素蛋白水凝胶(即丝素蛋白中药多糖水凝胶)。6) Determination of gel formation time: the centrifuge tube is inverted and the solution does not flow, that is, a silk fibroin hydrogel with Chinese medicine polysaccharide activity (ie, silk fibroin Chinese medicine polysaccharide hydrogel) is obtained.
经统计,采用本发明的制备方法制备丝素蛋白水凝胶,可以使丝素蛋白溶液的成胶时间缩短至5min以内。According to statistics, using the preparation method of the present invention to prepare the silk fibroin hydrogel can shorten the gelation time of the silk fibroin solution to within 5 minutes.
下面将结合具体实施例对本发明作进一步详细描述。The present invention will be described in further detail below with reference to specific embodiments.
实施例1:Example 1:
1)取400g机械粉碎的黄芪药材,利用水提醇沉法提取黄芪粗多糖。其中,所述利用水提醇沉法提取黄芪粗多糖的步骤,具体可以包括:按料液比1:10置于80℃水浴锅提取3次,合并滤液后浓缩至一定体积后,用Sevag法除蛋白(水提液:氯仿:正丁醇=25:5:1)。将除蛋白后的多糖溶液用4倍体积的95%乙醇醇沉、抽滤、干燥、得到黄芪粗多糖。1) Take 400 g of mechanically pulverized medicinal materials of Astragalus, and extract crude polysaccharides from Astragalus by water extraction and alcohol precipitation. Wherein, the step of extracting crude polysaccharide from Astragalus membranaceus by water extraction and alcohol precipitation method may specifically include: extracting 3 times in an 80° C. water bath according to a material-to-liquid ratio of 1:10, combining the filtrates and concentrating to a certain volume, using the Sevag method Protein removal (water extract: chloroform: n-butanol = 25:5:1). The polysaccharide solution after protein removal was ethanol-precipitated with 4 times the volume of 95% ethanol, suction filtered, and dried to obtain crude polysaccharide of Astragalus membranaceus.
2)将上述干燥的黄芪粗多糖在去离子水中透析3d,冷冻干燥,得到黄芪多糖,备用。2) Dialyzing the above-mentioned dried crude polysaccharide of Astragalus membranaceus in deionized water for 3 days, and freeze-drying to obtain Astragalus membranaceus polysaccharide, which is used for later use.
3)将一定质量脱胶蚕丝置于9.3M溴化锂溶液中,在65℃水浴锅中加热充分溶解后,将溶液冷却至室温转移至透析袋中,4℃蒸馏水透析3d。透析结束后将溶液置于离心机中离心,除去不溶杂质,离心条件4℃,20min,9000r/min;获得澄清的丝素蛋白溶液。3) A certain mass of degummed silk was placed in a 9.3M lithium bromide solution, heated in a 65°C water bath to fully dissolve, and the solution was cooled to room temperature, transferred to a dialysis bag, and dialyzed with distilled water at 4°C for 3 days. After the dialysis, the solution was centrifuged in a centrifuge to remove insoluble impurities, and the centrifugation conditions were 4° C., 20 min, and 9000 r/min; a clear silk fibroin solution was obtained.
4)将浓度为2%的丝素蛋白溶液与浓度为0.6%的黄芪多糖按体积比为1:4、3:2、1:1、2:3、4:1混合后,加入0.2~1mL浓度为100%乙醇,将混合液pH值调至4~6,置于37℃观察成胶时间。4) After mixing the silk fibroin solution with a concentration of 2% and the astragalus polysaccharide with a concentration of 0.6% in a volume ratio of 1:4, 3:2, 1:1, 2:3, 4:1, add 0.2-1 mL The concentration is 100% ethanol, the pH value of the mixture is adjusted to 4-6, and the gelation time is observed at 37°C.
5)将离心管倒置,溶液不流动,即得到丝素蛋白黄芪多糖水凝胶,如图1所示。5) Invert the centrifuge tube and the solution does not flow to obtain a hydrogel of silk fibroin astragalus polysaccharide, as shown in FIG. 1 .
该实施例中,各体积比下的成胶时间分别为:1h以内未成胶、1min30s、1min47s、2min30s、1min54s。In this embodiment, the gel-forming times under each volume ratio are respectively: no gel-forming within 1 hour, 1min30s, 1min47s, 2min30s, and 1min54s.
图2是采用该实施例1制备得到的具有中药多糖活性的丝素蛋白水凝胶包被牛血清白蛋白的释放曲线图。FIG. 2 is a release curve diagram of bovine serum albumin coated with silk fibroin hydrogel with traditional Chinese medicine polysaccharide activity prepared by using the example 1. FIG.
试验过程:配置含有0.01g/mL牛血清白蛋白的多糖溶液制备水凝胶,以10mL的PBS作为释放介质加入到装有水凝胶的EP管中,37℃摇床中孵育,每隔一段时间测其溶液吸光度。Test process: prepare a hydrogel with a polysaccharide solution containing 0.01 g/mL bovine serum albumin, add 10 mL of PBS as the release medium to the EP tube containing the hydrogel, incubate at 37 °C in a shaker, and incubate at intervals time to measure the absorbance of the solution.
由图2可知:以pH=7.4的PBS为释放介质,每间隔4h为一次测样点,共测24h,24h时释放率达到80%以上。It can be seen from Figure 2 that PBS with pH=7.4 was used as the release medium, and every 4h was used as a sampling point for a total of 24h, and the release rate reached more than 80% at 24h.
实施例2:Example 2:
1)取400g机械粉碎的黄精药材,按料液比1:10置于80℃水浴锅提取3次,合并滤液后浓缩至一定体积后用Sevag法除蛋白(水提液:氯仿:正丁醇=25:5:1)。将除蛋白后的多糖溶液用4倍体积的95%乙醇醇沉、抽滤、干燥、得到黄精粗多糖。1) Take 400g of mechanically pulverized Polygonatum chinensis medicinal materials, place them in an 80°C water bath to extract 3 times at a material-to-liquid ratio of 1:10, combine the filtrates and concentrate them to a certain volume and then use the Sevag method to remove protein (water extract: chloroform: n-butanol). = 25:5:1). The polysaccharide solution after protein removal was ethanol precipitated with 4 times the volume of 95% ethanol, suction filtered, and dried to obtain Polygonatum polysaccharide crude polysaccharide.
2)将上述干燥的黄精粗多糖在去离子水中透析3d,冷冻干燥、得到黄精多糖,备用。2) Dialyzing the above-mentioned dried polysaccharide polysaccharide in deionized water for 3 days, freeze-drying to obtain polysaccharide polysaccharide, and standby.
3)将一定质量脱胶蚕丝置于9.3M溴化锂溶液中,在65℃水浴锅中加热充分溶解后,将溶液冷却至室温转移至透析袋中,4℃蒸馏水透析3d。透析结束后将溶液置于离心机中离心,除去不溶杂质,离心条件4℃,20min,9000r/min;获得澄清的丝素蛋白溶液。3) A certain quality of degummed silk was placed in a 9.3M lithium bromide solution, heated in a 65°C water bath to fully dissolve, and the solution was cooled to room temperature and transferred to a dialysis bag, and dialyzed with distilled water at 4°C for 3 days. After the dialysis, the solution was centrifuged in a centrifuge to remove insoluble impurities, and the centrifugation conditions were 4°C, 20 min, and 9000 r/min; a clear silk fibroin solution was obtained.
4)将浓度为4%的丝素蛋白溶液与浓度为1.6%的黄精多糖按体积比为1:4、3:2、1:1、2:3、4:1混合后,加入0.2~1mL浓度为85%乙醇,将混合液调pH值至4~6,置于室温观察成胶时间。4) After mixing the silk fibroin solution with a concentration of 4% and the polysaccharide polysaccharide with a concentration of 1.6% in a volume ratio of 1:4, 3:2, 1:1, 2:3, 4:1, add 0.2-1 mL The concentration is 85% ethanol, the pH value of the mixture is adjusted to 4-6, and the gelation time is observed at room temperature.
5)将离心管倒置,溶液不流动,即得到丝素蛋白黄精多糖水凝胶。5) Invert the centrifuge tube, and the solution does not flow to obtain a hydrogel of silk fibroin polysaccharide.
该实施例中,各体积比下的成胶时间分别为:1h内未成胶、4min、4min10s、3min30s、3min56s。In this embodiment, the gel-forming times under each volume ratio are respectively: no gel-forming within 1 hour, 4 min, 4 min 10 s, 3 min 30 s, and 3 min 56 s.
图3是本发明上述实施例2制备的具有中药多糖活性的丝素蛋白水凝胶的扫描电镜图,由图3可知:所制备的水凝胶具有明显的三维网状结构,多孔的内部结构、孔隙间的相互连接,可应用于药物释放,有利于细胞的粘附和迁移。Fig. 3 is a scanning electron microscope image of the silk fibroin hydrogel with Chinese medicine polysaccharide activity prepared in the above-mentioned embodiment 2 of the present invention. It can be seen from Fig. 3 that the prepared hydrogel has an obvious three-dimensional network structure and a porous internal structure. , The interconnection between pores can be applied to drug release, which is beneficial to cell adhesion and migration.
Claims (10)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011510562.2A CN115246938B (en) | 2020-12-18 | 2020-12-18 | Silk fibroin hydrogel with traditional Chinese medicine polysaccharide activity, preparation method and application thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011510562.2A CN115246938B (en) | 2020-12-18 | 2020-12-18 | Silk fibroin hydrogel with traditional Chinese medicine polysaccharide activity, preparation method and application thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN115246938A true CN115246938A (en) | 2022-10-28 |
| CN115246938B CN115246938B (en) | 2024-05-03 |
Family
ID=83696317
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202011510562.2A Active CN115246938B (en) | 2020-12-18 | 2020-12-18 | Silk fibroin hydrogel with traditional Chinese medicine polysaccharide activity, preparation method and application thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN115246938B (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116808111A (en) * | 2023-08-21 | 2023-09-29 | 长春中医药大学 | Hydrogel film loaded with traditional Chinese medicine, preparation method thereof and application of hydrogel film in resisting osteosarcoma |
| CN116942563A (en) * | 2023-08-03 | 2023-10-27 | 广西壮族自治区蚕业技术推广站 | Phellinus linteus polysaccharide-loaded nano microsphere and preparation and application thereof |
| CN117122567A (en) * | 2023-08-28 | 2023-11-28 | 哈尔滨工业大学重庆研究院 | An emulsion gel capable of loading and delivering amphiphilic drugs, preparation method and application |
Citations (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040266992A1 (en) * | 2001-09-11 | 2004-12-30 | Claudio Migliaresi | Method for the preparation of silk fibron hydrogels |
| CN102688525A (en) * | 2012-05-07 | 2012-09-26 | 东南大学 | Bio-macromolecular hydrogel and preparation method thereof |
| CN102836465A (en) * | 2012-08-30 | 2012-12-26 | 浙江星月生物科技股份有限公司 | Silk-fibroi and hyaluronic-acid (HA) composite gel for injection and preparation and application thereof |
| CN103709418A (en) * | 2013-12-13 | 2014-04-09 | 苏州大学 | Silk fibroin/alginate hydrogel material and preparation method thereof |
| US20140315828A1 (en) * | 2013-04-22 | 2014-10-23 | Allergan, Inc. | Cross-linked silk-hyaluronic acid compositions |
| CN107189081A (en) * | 2017-06-07 | 2017-09-22 | 兰州理工大学 | A kind of Preparation method and use of multi-functional polysaccharide hydrogel |
| CN109431971A (en) * | 2018-10-19 | 2019-03-08 | 广州医科大学 | A kind of injectable carries liquid medicine gel and preparation method thereof |
| WO2019047043A1 (en) * | 2017-09-06 | 2019-03-14 | 南通纺织丝绸产业技术研究院 | Silk fibroin/chitosan composite smart hydrogel and preparation method therefor |
| CN110804194A (en) * | 2019-12-04 | 2020-02-18 | 黄春美 | Degradable modified polylactic acid-polyethylene glycol hydrogel and preparation method thereof |
| KR20200036664A (en) * | 2018-09-28 | 2020-04-07 | 서울대학교산학협력단 | Hyaluronic acid-silk fibroin hybrid hydrogels, and preparation method thereof |
| US20200262937A1 (en) * | 2017-09-27 | 2020-08-20 | Association For The Advancement Of Tissue Engineering Cell Based Technologies & Therapies (A4Tec)- | High molecular weight chitosan, process for obtaining and uses thereof |
-
2020
- 2020-12-18 CN CN202011510562.2A patent/CN115246938B/en active Active
Patent Citations (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040266992A1 (en) * | 2001-09-11 | 2004-12-30 | Claudio Migliaresi | Method for the preparation of silk fibron hydrogels |
| CN102688525A (en) * | 2012-05-07 | 2012-09-26 | 东南大学 | Bio-macromolecular hydrogel and preparation method thereof |
| CN102836465A (en) * | 2012-08-30 | 2012-12-26 | 浙江星月生物科技股份有限公司 | Silk-fibroi and hyaluronic-acid (HA) composite gel for injection and preparation and application thereof |
| US20140315828A1 (en) * | 2013-04-22 | 2014-10-23 | Allergan, Inc. | Cross-linked silk-hyaluronic acid compositions |
| CN103709418A (en) * | 2013-12-13 | 2014-04-09 | 苏州大学 | Silk fibroin/alginate hydrogel material and preparation method thereof |
| CN107189081A (en) * | 2017-06-07 | 2017-09-22 | 兰州理工大学 | A kind of Preparation method and use of multi-functional polysaccharide hydrogel |
| WO2019047043A1 (en) * | 2017-09-06 | 2019-03-14 | 南通纺织丝绸产业技术研究院 | Silk fibroin/chitosan composite smart hydrogel and preparation method therefor |
| US20200262937A1 (en) * | 2017-09-27 | 2020-08-20 | Association For The Advancement Of Tissue Engineering Cell Based Technologies & Therapies (A4Tec)- | High molecular weight chitosan, process for obtaining and uses thereof |
| KR20200036664A (en) * | 2018-09-28 | 2020-04-07 | 서울대학교산학협력단 | Hyaluronic acid-silk fibroin hybrid hydrogels, and preparation method thereof |
| CN109431971A (en) * | 2018-10-19 | 2019-03-08 | 广州医科大学 | A kind of injectable carries liquid medicine gel and preparation method thereof |
| CN110804194A (en) * | 2019-12-04 | 2020-02-18 | 黄春美 | Degradable modified polylactic acid-polyethylene glycol hydrogel and preparation method thereof |
Non-Patent Citations (2)
| Title |
|---|
| WI ABDEL-FATTAH,等: "Influence of the protocol of fibroin extraction on the antibiotic activities of the constructed composites", 《PROGRESS IN BIOMATERIALS》, vol. 4, no. 2, 31 December 2015 (2015-12-31), pages 77 - 88 * |
| 张悦,等: "丝素蛋白水凝胶在生物医学领域的应用研究进展", 《现代丝绸科学与技术》, vol. 33, no. 3, 31 December 2018 (2018-12-31), pages 32 - 38 * |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116942563A (en) * | 2023-08-03 | 2023-10-27 | 广西壮族自治区蚕业技术推广站 | Phellinus linteus polysaccharide-loaded nano microsphere and preparation and application thereof |
| CN116808111A (en) * | 2023-08-21 | 2023-09-29 | 长春中医药大学 | Hydrogel film loaded with traditional Chinese medicine, preparation method thereof and application of hydrogel film in resisting osteosarcoma |
| CN116808111B (en) * | 2023-08-21 | 2023-12-26 | 长春中医药大学 | Hydrogel film loaded with traditional Chinese medicine, preparation method thereof and application of hydrogel film in resisting osteosarcoma |
| CN117122567A (en) * | 2023-08-28 | 2023-11-28 | 哈尔滨工业大学重庆研究院 | An emulsion gel capable of loading and delivering amphiphilic drugs, preparation method and application |
Also Published As
| Publication number | Publication date |
|---|---|
| CN115246938B (en) | 2024-05-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN115246938B (en) | Silk fibroin hydrogel with traditional Chinese medicine polysaccharide activity, preparation method and application thereof | |
| CN104922734B (en) | Promote injectable chitosan composite aquogel of myocardial repair and preparation method thereof | |
| CN112920425B (en) | Medical hydrogel composition, medical hydrogel and preparation method thereof | |
| CN113174080B (en) | Biological glass nanofiber porous scaffold and preparation and application thereof | |
| CN106267309B (en) | alginate composite antibacterial dressing and preparation method thereof | |
| CN115487358B (en) | Gel composite scaffold for cartilage tissue repair and preparation method thereof | |
| CN103462883A (en) | Matrine diatomic alcohol plastid temperature-sensitive gel and preparation method thereof | |
| CN118286150A (en) | Rhein-loaded double-dynamic cross-linked polysaccharide-based hydrogel and preparation method thereof | |
| CN109395162B (en) | A kind of preparation method of natural protein-based biomimetic structure bone scaffold | |
| CN114230814A (en) | Hydrogel carrying traumatology yellow water and preparation method thereof | |
| CN115040689B (en) | A kind of high fluidity hydroxyapatite nano material and preparation method thereof | |
| CN108295029A (en) | A kind of injection Multifunctional composite water gel and preparation method thereof | |
| CN105687036A (en) | Rhizoma bletillae skin care product and method for preparing same | |
| CN119285734A (en) | A method for extracting and purifying mussel mucin | |
| CN109999070A (en) | A kind of asiaticoside liposome and preparation process | |
| CN115558690B (en) | Cockroach polypeptide part and preparation method and application thereof | |
| CN115887781B (en) | Preparation method of injectable hydrogel for cartilage injury repair | |
| WO2024104261A1 (en) | Sustained-release film agent for mucous membrane and preparation method therefor | |
| CN101912426B (en) | Method for preparing ginkgo exocarp anti-tumor effective part and preparation thereof | |
| CN104127473A (en) | Pharmaceutical composition for treating bone diseases, injection thereof and preparation methods thereof | |
| CN107184545A (en) | A kind of konjaku glucomannan gel for eye and preparation method thereof | |
| CN115487357A (en) | A kind of immune isolation cell encapsulation capsule with controllable pore size and its preparation method and application | |
| CN102600250A (en) | In-situ gel sustained-release preparation of Ranunculus ternatus Thunb., and its preparation method | |
| CN120305455B (en) | A high-performance composite hydrogel, preparation method and application thereof | |
| CN112957374A (en) | Dog serum deproteinized eye gel for dogs and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |